Skip to content
Voyageur Pharmaceuticals LogoVoyageur Pharmaceuticals LogoVoyageur Pharmaceuticals Logo
  • Home
  • About
    • Mission
    • History
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Message from the CEO
  • Products
    • About Barium
    • SmoothX
      • Product Information
      • Clinical Data
    • Pipeline
  • Sustainability
  • News
  • Investors
  • Contact

Voyageur Pharmaceuticals Announces IRR of 137% & NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project

Published On: January 11, 2022|Categories: Company News|

PEA News Jan 11 2021 (1)

Previous
Next
Contact Us
  • Dome Tower 800, 333 7 Ave. S.W.
    Calgary, Alberta T2P 2Z1

  • +1.403.923.5944

  • info@vpharma.ca
Search
Page load link
Go to Top